Adia Med net loss narrows to $122,107 in FY26 H1; revenue more than doubled to $661,660 vs FY25 H1
ADIA•Going-concern warning remains
Management flagged substantial doubt about going concern, citing a $16,095,589 accumulated deficit despite a quarterly swing to net income of $40,418.
Profit and expenses both increased
Gross profit rose to $350,157 from $39,975 as cost of revenue increased to $311,503 from $149,935.
Operating expenses increased to $450,248 from $267,105, driven by higher legal and professional fees of $160,731.
H1 loss narrows as revenue more than doubles
Adia Med posted a net loss of $122,107 for the six months ended June 30, 2026, narrowing from $240,216.
Revenue climbed to $661,660, more than doubled from $189,910, led by $434,670 from medical procedures.
